AMGEN INC Cost of Revenue 2011-2025 | AMGN
Beta
What is cost of revenue?
Cost of revenue includes the direct costs attributable to producing goods or delivering services sold by the company.
What is AMGEN INC's current cost of revenue?
AMGEN INC (AMGN) annual cost of revenue for 2025 was $12.04B, a 6.39% decline from 2024. AMGEN INC cost of revenue for the quarter ending December 31, 2025 was $2.98B.
What was AMGEN INC's cost of revenue in 2024?
AMGEN INC annual cost of revenue for 2024 was $12.86B, a 52.15% increase from 2023.
What was AMGEN INC's cost of revenue in 2023?
AMGEN INC annual cost of revenue for 2023 was $8.45B, a 31.92% increase from 2022.
What is AMGEN INC's 5-year cost of revenue CAGR?
AMGEN INC cost of revenue grew at a compound annual growth rate (CAGR) of 14.34% from FY2020 to FY2025, going from $6.16B to $12.04B over 5 years.
Cost of Revenue History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+14.3%
FY2020
$6.16B
→
FY2025
$12.04B
111213141516171819202122232425
5 years selected
Cost of Revenue History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $12.04B | -6.4% | 10-K |
| FY2024 | $12.86B | +52.1% | 10-K |
| FY2023 | $8.45B | +31.9% | 10-K |
| FY2022 | $6.41B | -0.7% | 10-K |
| FY2021 | $6.45B | +4.8% | 10-K |
| FY2020 | $6.16B | +41.4% | 10-K |
| FY2019 | $4.36B | +6.2% | 10-K |
| FY2018 | $4.10B | +0.8% | 10-K |
| FY2017 | $4.07B | -2.2% | 10-K |
| FY2016 | $4.16B | -1.5% | 10-K |
| FY2015 | $4.23B | -4.4% | 10-K |
| FY2014 | $4.42B | +32.2% | 10-K |
| FY2013 | $3.35B | +4.6% | 10-K |
| FY2012 | $3.20B | +18.1% | 10-K |
| FY2011 | $2.71B | - | 10-K |
Company: AMGEN INCTicker: AMGNSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →